AKT1 and neoplasm: In PDAC, enhanced cholinergic signals could directly inhibit MAPK/EGFR, and PI3K/AKT pathways which were mediated by type 1 muscarinic receptors (CHRM1), but also could indirectly suppress tumor progression by inhibiting tumor stem cell transformation [27].